Currently set to Index
Currently set to Follow

Scopio

Revolutionizing diagnostic procedures by providing end-to-end digital cytology solutions thereby helping clinics of all sizes embrace digital innovation and unlock diagnostic insights.

Ceidos

C-Netics is an innovative lab device to fully automatize cell expansion monitoring in a closed system, ensuring better outcomes for a much lower price.

ClearCut Medical

ClearCut Medical has developed a novel, portable imaging system platform bringing the power and trust of MRI into the operating room

Neteera

Continuous, contactless, passive vital signs and bio-data monitoring solution that eliminates the need for device manipulation, removal of clothing, and caregiver presence.

Neurocare

The company delivers personalized treatment for a range of mental health treatment areas in a unique Digital Therapy Platform (DTP).

Cardiolyse

Cardiolyse is a cloud ECG & HRV analytics platform

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Vivior

Personalized Vision Performance: The first “Fitbit for the eyes”

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Medikura (XO Life)

The real-world evidence platform for the efficacy and safety of drugs

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Emperra

Fighting the diabetes pandemic with a telemedicine solution

Munevo

Venture Category: MedTech

Smartglasses helping people with disabilities to achieve independent mobility

Surge-on Medical

Venture Category: MedTech
Business Phase: Sales Expansion
Professional Investors: 1 VC, 2 Family Offices

Lipozyt Marker

Diagnostic tests for the personalized treatment of type 2 diabetes

This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de

Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.

I agree

Invest in Health

Successfully funded on our sister platform aescuvest.de

Get notified

of new campaigns and news.
We do not sell or share your data to third parties. View our Privacy notice

By clicking on 'Sign up', you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.